M. Ahmed, N. Tofazzal, R. Nirula, J. Thomas, A. Dhanasekaran
This paper presents a patient of primary submandibular gland adenocarcinoma later presenting with renal metastasis. Renal cancers are known for its predisposition to unusual metastasis to other organs. On the contrary, renal metastasis from salivary gland tumours are extremely rare with none reported from the submandibular gland to date. Hence the significance of adequate history taking, immunohistochemical identification of pathology and multidisciplinary approach in the management of such rare clinical presentation is discussed here. Metastatic disease should always be a differential when evaluating cancer patients regardless of the interval since previous disease or rarity of occurrence.
{"title":"Renal Metastasis from Submandibular Gland Adenocarcinoma First Reported Patient in Literature History","authors":"M. Ahmed, N. Tofazzal, R. Nirula, J. Thomas, A. Dhanasekaran","doi":"10.22374/JELEU.V2I3.30","DOIUrl":"https://doi.org/10.22374/JELEU.V2I3.30","url":null,"abstract":"This paper presents a patient of primary submandibular gland adenocarcinoma later presenting with renal metastasis. Renal cancers are known for its predisposition to unusual metastasis to other organs. On the contrary, renal metastasis from salivary gland tumours are extremely rare with none reported from the submandibular gland to date. Hence the significance of adequate history taking, immunohistochemical identification of pathology and multidisciplinary approach in the management of such rare clinical presentation is discussed here. Metastatic disease should always be a differential when evaluating cancer patients regardless of the interval since previous disease or rarity of occurrence.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114439332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Spindle cell lipoma (SCL) in the scrotum is a very rare presentation with only a few cases reported in the literature. The most common sites for this benign lesion are the neck, shoulder, and back. We present a 72-year-old male patient with painless swelling on the left half of the scrotum with a histopathological diagnosis of SCL.
{"title":"Spindle Cell Lipoma of Scrotum","authors":"M. Iqbal, S. Agarwal, I. Shergill","doi":"10.22374/JELEU.V2I2.46","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.46","url":null,"abstract":"Spindle cell lipoma (SCL) in the scrotum is a very rare presentation with only a few cases reported in the literature. The most common sites for this benign lesion are the neck, shoulder, and back. We present a 72-year-old male patient with painless swelling on the left half of the scrotum with a histopathological diagnosis of SCL.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133223243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Hosny, Jennifer Clark, M. Nosseir, M. Al-Attar, Mohammad Masaarane, N. Cockburn, Izzati Samsudin
Transurethral resection of bladder tumour (TURBT) is the first step in management of bladder cancers. A urology trainee in the UK must do at least 120 procedures during their training years before being a consultant. In our article, we are reporting a retrospective audit of the quality of TURBT across 2 major cancer centres in Lancashire. We assessed the adherence of surgical procedure to the national and international guidelines among different grades of urological surgeons who work in the 2 trusts.
{"title":"A Retrospective Audit of the TURBT Quality in Two Major Cancer Centres in Lancashire","authors":"K. Hosny, Jennifer Clark, M. Nosseir, M. Al-Attar, Mohammad Masaarane, N. Cockburn, Izzati Samsudin","doi":"10.22374/JELEU.V2I2.41","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.41","url":null,"abstract":"Transurethral resection of bladder tumour (TURBT) is the first step in management of bladder cancers. A urology trainee in the UK must do at least 120 procedures during their training years before being a consultant. In our article, we are reporting a retrospective audit of the quality of TURBT across 2 major cancer centres in Lancashire. We assessed the adherence of surgical procedure to the national and international guidelines among different grades of urological surgeons who work in the 2 trusts.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132972279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectiveTo critically analyse the efficacy and safety of continuous saline bladder irrigation versus single installation of mitomycin-C (MMC) after transurethral resection of bladder tumour (TURBT) in patients with low to intermediate risk non-muscle invasive bladder cancer. Materials and MethodsThe question in consideration best merits answer by critically reviewing and analyzing the literature and finally to provide the recommendation about the relevance of the conclusions from the literature. A search study identifies the relevant literature from the well-known academic databases in the context of the re-search question. The particular sets of the key words are used in different formats to search the literature. The literature has been thoroughly reviewed and analyzed for the strengths and limitations. Specific data was critically taken for analysis depending upon the type of literature articles with special reference to their usefulness, knowledge, attitudes, transferability, validity/reliability and strength of conclusions. ResultsA total of 6 papers meeting the inclusion criteria, which compared the results of the efficacy and safety between intravesical chemotherapy and continuous saline bladder irrigation (CSBI) were critically analyzed. ConclusionCSBI cannot replace MMC in terms of its efficacy in the prevention of recurrence and progression but because of the better safety profile can be used as an alternative in patients with low to intermediate risk bladder cancers after TURBT.
{"title":"Comparison of Efficacy and Safety between Post-operative Intra-vesical Instillation of Mitomycin-C and Continuous Saline Bladder Irrigation (CSBI) after TURBT in Non-muscle Invasive Bladder Cancers","authors":"A. Bhat, Z. Bhat","doi":"10.22374/JELEU.V2I2.40","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.40","url":null,"abstract":"ObjectiveTo critically analyse the efficacy and safety of continuous saline bladder irrigation versus single installation of mitomycin-C (MMC) after transurethral resection of bladder tumour (TURBT) in patients with low to intermediate risk non-muscle invasive bladder cancer. \u0000Materials and MethodsThe question in consideration best merits answer by critically reviewing and analyzing the literature and finally to provide the recommendation about the relevance of the conclusions from the literature. A search study identifies the relevant literature from the well-known academic databases in the context of the re-search question. The particular sets of the key words are used in different formats to search the literature. The literature has been thoroughly reviewed and analyzed for the strengths and limitations. Specific data was critically taken for analysis depending upon the type of literature articles with special reference to their usefulness, knowledge, attitudes, transferability, validity/reliability and strength of conclusions. \u0000ResultsA total of 6 papers meeting the inclusion criteria, which compared the results of the efficacy and safety between intravesical chemotherapy and continuous saline bladder irrigation (CSBI) were critically analyzed. ConclusionCSBI cannot replace MMC in terms of its efficacy in the prevention of recurrence and progression but because of the better safety profile can be used as an alternative in patients with low to intermediate risk bladder cancers after TURBT.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122830489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kalyan Gudaru, L. T. Blanco, D. Castellani, Hegel Trujillo Santamaria, M. Pelayo-Nieto, E. Linden‐Castro, M. Wroclawski, Mateus Cosentino Bellote, J. Inarritu, R. D. da Silva, V. Gauhar, Zainal Adwin, J. Teoh
Background and Objectives There is an increasing use of social media amongst the urological community. However, it is difficult to identify urological data on various social media platforms in an efficient manner. We proposed a hashtag, #UroSoMe, to be used when posting urology-related content in the social media platforms. The objectives of this article are to describe how #UroSoMe was developed, and to report the data of the first month of #UroSoMe. Material and Methods The hashtag, #UroSoMe, was introduced to the urological community. The #UroSoMe working group was formed, and the members actively invited and encouraged people to use the hashtag #UroSoMe when posting urology-related contents. After the #UroSoMe (@so_uro) platform on twitter had grown to more than 300 users, the first live event of online case discussion, i.e. #LiveCaseDiscussions, was conducted. A prospective observational study of the hashtag #UroSoMe Twitter activity during the first month of its usage from 14 December 2018 to 13 January 2019 was evaluated. Outcome measures included number of users, number of tweets, user location, top tweeters, top hashtags used and interactions. Analysis was performed using NodeXL (Social Media Research Foundation; California, USA; https://www.smrfoundation.org/nodexl/), Symplur (https:// www.symplur.com) and Twitonomy (https://www.twitonomy.com). Results The first month of #UroSoMe activity documented 1373 tweets/retweets by 1008 tweeters with 17698 mentions and 1003 replies. The #LiveCaseDiscussions was able to achieve a potential reach of 2,033,352 Twitter users. The top tweets mainly included cases presented by #UroSoMe working group members during #LiveCaseDiscussions. The twitonomy map showed participation from 214 geographical locations. The major groups of participants using the hashtag #UroSoMe were ‘Researcher/Academic’ and ‘Doctor’. The twitter account of #UroSoMe (@so_uro) has now grown to more than 1000 followers. Conclusions Social media is an excellent platform for interaction amongst the urological community. The results demonstrated that #UroSoMe was able to achieve wide spread engagement from all over the world.
背景与目的泌尿外科社区越来越多地使用社交媒体。然而，很难有效地识别各种社交媒体平台上的泌尿科数据。我们提议在社交媒体平台上发布泌尿科相关内容时使用#UroSoMe标签。本文的目的是描述#UroSoMe是如何发展的，并报告#UroSoMe第一个月的数据。#UroSoMe标签被引入泌尿界。#UroSoMe工作组成立了，成员们积极邀请和鼓励人们在发布泌尿相关内容时使用#UroSoMe标签。在推特上的#UroSoMe (@so_uro)平台发展到300多名用户后，发起了第一个在线案例讨论的现场活动，即#LiveCaseDiscussions。对#UroSoMe标签在2018年12月14日至2019年1月13日使用的第一个月内的Twitter活动进行了前瞻性观察研究。结果指标包括用户数量、推文数量、用户位置、最热门的推特用户、使用的最热门标签和互动。分析采用NodeXL (Social Media Research Foundation;美国加州;https://www.smrfoundation.org/nodexl/)、Symplur (https:// www.symplur.com)和Twitonomy (https://www.twitonomy.com)。结果#UroSoMe活动的第一个月记录了1008名推特者的1373条推文/转发，17698次提及和1003次回复。#LiveCaseDiscussions能够达到2,033,352个Twitter用户的潜在覆盖范围。排名靠前的推文主要包括#UroSoMe工作组成员在# livecasediscussion中提出的案例。twitonomy地图显示了来自214个地理位置的参与。使用#UroSoMe标签的主要参与者群体是“研究员/学者”和“医生”。#UroSoMe (@so_uro)的推特账号现在已经有1000多名粉丝。结论社交媒体是泌尿外科交流的良好平台。结果表明，#UroSoMe能够获得来自世界各地的广泛参与。
{"title":"Connecting the Urological Community : The #UroSoMe Experience","authors":"Kalyan Gudaru, L. T. Blanco, D. Castellani, Hegel Trujillo Santamaria, M. Pelayo-Nieto, E. Linden‐Castro, M. Wroclawski, Mateus Cosentino Bellote, J. Inarritu, R. D. da Silva, V. Gauhar, Zainal Adwin, J. Teoh","doi":"10.22374/JELEU.V2I2.44","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.44","url":null,"abstract":"Background and Objectives \u0000There is an increasing use of social media amongst the urological community. However, it is difficult to identify urological data on various social media platforms in an efficient manner. We proposed a hashtag, #UroSoMe, to be used when posting urology-related content in the social media platforms. The objectives of this article are to describe how #UroSoMe was developed, and to report the data of the first month of #UroSoMe. \u0000 \u0000Material and Methods \u0000The hashtag, #UroSoMe, was introduced to the urological community. The #UroSoMe working group was formed, and the members actively invited and encouraged people to use the hashtag #UroSoMe when posting urology-related contents. After the #UroSoMe (@so_uro) platform on twitter had grown to more than 300 users, the first live event of online case discussion, i.e. #LiveCaseDiscussions, was conducted. A prospective observational study of the hashtag #UroSoMe Twitter activity during the first month of its usage from 14 December 2018 to 13 January 2019 was evaluated. Outcome measures included number of users, number of tweets, user location, top tweeters, top hashtags used and interactions. Analysis was performed using NodeXL (Social Media Research Foundation; California, USA; https://www.smrfoundation.org/nodexl/), Symplur (https:// www.symplur.com) and Twitonomy (https://www.twitonomy.com). \u0000 \u0000Results \u0000The first month of #UroSoMe activity documented 1373 tweets/retweets by 1008 tweeters with 17698 mentions and 1003 replies. The #LiveCaseDiscussions was able to achieve a potential reach of 2,033,352 Twitter users. The top tweets mainly included cases presented by #UroSoMe working group members during #LiveCaseDiscussions. The twitonomy map showed participation from 214 geographical locations. The major groups of participants using the hashtag #UroSoMe were ‘Researcher/Academic’ and ‘Doctor’. The twitter account of #UroSoMe (@so_uro) has now grown to more than 1000 followers. \u0000 \u0000Conclusions \u0000Social media is an excellent platform for interaction amongst the urological community. The results demonstrated that #UroSoMe was able to achieve wide spread engagement from all over the world.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"109 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117217081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectiveClarify the role of IPSS questionnaire for post TURP operation patients, to assess and streamline best follow-up protocols Materials and MethodsWe identified 87 consecutive patients over 6 months undergoing standardized bipolar TURP. We retro-spectively reviewed patients at 3 months in follow-up clinic, where we performed tests including Qmax, Post-void residual (PVR) and IPSS (International Prostate Symptom Score). We identified patients who were discharged or underwent a change in standard management at this point, and used ROC (Receiver Operating Curve) curve analysis to identify the tools which showed the best ability to predict this decision. ResultsROC curve analysis suggested Qmax (AUC: 0.7751) and IPSS (AUC 0.8571) were the best tools to predict a change in management. Given the IPSS tool is a questionnaire, thus holding most promise to streamline protocols, we applied Youden-J test to show IPSS=8 cut-off was best to identify management changes. ConclusionThe IPSS tool is able to predict a need for change in management in post TURP patients at 3 months. This will allow a simple triage system to provide an efficient and effective decision-making process for discharge without the need for clinic attendance.
{"title":"Review of IPSS Questionnaire in Postoperative Transurethral Resection of Prostate (TURP) for Streamlining Follow-up Protocols","authors":"G. Broadley, G. Delves, S. Khwaja","doi":"10.22374/JELEU.V2I2.36","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.36","url":null,"abstract":"ObjectiveClarify the role of IPSS questionnaire for post TURP operation patients, to assess and streamline best follow-up protocols \u0000Materials and MethodsWe identified 87 consecutive patients over 6 months undergoing standardized bipolar TURP. We retro-spectively reviewed patients at 3 months in follow-up clinic, where we performed tests including Qmax, Post-void residual (PVR) and IPSS (International Prostate Symptom Score). We identified patients who were discharged or underwent a change in standard management at this point, and used ROC (Receiver Operating Curve) curve analysis to identify the tools which showed the best ability to predict this decision. ResultsROC curve analysis suggested Qmax (AUC: 0.7751) and IPSS (AUC 0.8571) were the best tools to predict a change in management. Given the IPSS tool is a questionnaire, thus holding most promise to streamline protocols, we applied Youden-J test to show IPSS=8 cut-off was best to identify management changes. \u0000ConclusionThe IPSS tool is able to predict a need for change in management in post TURP patients at 3 months. This will allow a simple triage system to provide an efficient and effective decision-making process for discharge without the need for clinic attendance.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"207 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114004193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Tasleem, S. Yallappa, M. Mikhail, T. Amer, Peter Pietrzak, P. Acher, A. Young
Patients are living longer with an increasing number of co-morbidities. Minimally invasive ureterorenoscopy (URS) to manage upper tract calculi or transitional cell carcinoma (TCC) can be performed under general or spinal anaesthesia, however certain co-morbid patients are not suitable for this and may benefit from a different approach. We report on URS under local anaesthesia (LA) using intra-ureteric marcaine as the primary form of anaesthesia. We also aimed to perform a robust systematic review of this topic. A retrospective analysis over 6 years was undertaken on all patients who underwent URS for calculi or TCC under LA, with the use of intra-urethral lidocaine gel (2%) and intra-ureteric marcaine (0.5%, 20ml) with sedoanalgesia as an adjunct. A systematic review and all English Language articles on ureteroscopic procedures with the use of LA with or without intravenous sedoanalgesia were selected and data extracted. In our case series, twelve patients had a total of 42 procedures. Stone size varied from 4-35mm. Twenty-two percent of procedures (9/41) did not require any sedation or intravenous analgesia as an adjunct to the bupivacaine with a further 49% (20/41) requiring midazolam. (The anaesthetic chart was not available for one procedure). No procedures were abandoned and there were no conversions to general/spinal anaesthesia. There were no complications secondary to the use of LA. Eighty-one percent of cases (34/42) were performed as day-case or overnight stays. The complication rate was similar to that for conventional anaesthesia. The systematic review yielded 1121 procedures from 11 papers and 7 countries. In 32 cases the procedure was converted to general anaesthesia. Stone clearance rates were between 78-100%. The procedures were well tolerated in 80-90% of cases. This study highlights that URS can be safely performed under LA. It is well tolerated and represents an option for carefully selected patients who have been adequately counselled, and who would be at high risk from anaesthesia. Such patients may otherwise be considered “unfit” for endourological intervention.
{"title":"A Systematic Review and Single-Centre Experience of Ureterorenoscopy Under Local Anesthetic: A Safer Option for Anesthetically High-Risk Patients?","authors":"A. Tasleem, S. Yallappa, M. Mikhail, T. Amer, Peter Pietrzak, P. Acher, A. Young","doi":"10.22374/JELEU.V2I2.39","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.39","url":null,"abstract":"Patients are living longer with an increasing number of co-morbidities. Minimally invasive ureterorenoscopy (URS) to manage upper tract calculi or transitional cell carcinoma (TCC) can be performed under general or spinal anaesthesia, however certain co-morbid patients are not suitable for this and may benefit from a different approach. We report on URS under local anaesthesia (LA) using intra-ureteric marcaine as the primary form of anaesthesia. We also aimed to perform a robust systematic review of this topic. \u0000 \u0000A retrospective analysis over 6 years was undertaken on all patients who underwent URS for calculi or TCC under LA, with the use of intra-urethral lidocaine gel (2%) and intra-ureteric marcaine (0.5%, 20ml) with sedoanalgesia as an adjunct. A systematic review and all English Language articles on ureteroscopic procedures with the use of LA with or without intravenous sedoanalgesia were selected and data extracted. \u0000 \u0000In our case series, twelve patients had a total of 42 procedures. Stone size varied from 4-35mm. Twenty-two percent of procedures (9/41) did not require any sedation or intravenous analgesia as an adjunct to the bupivacaine with a further 49% (20/41) requiring midazolam. (The anaesthetic chart was not available for one procedure). No procedures were abandoned and there were no conversions to general/spinal anaesthesia. There were no complications secondary to the use of LA. Eighty-one percent of cases (34/42) were performed as day-case or overnight stays. The complication rate was similar to that for conventional anaesthesia. The systematic review yielded 1121 procedures from 11 papers and 7 countries. In 32 cases the procedure was converted to general anaesthesia. Stone clearance rates were between 78-100%. The procedures were well tolerated in 80-90% of cases. \u0000 \u0000This study highlights that URS can be safely performed under LA. It is well tolerated and represents an option for carefully selected patients who have been adequately counselled, and who would be at high risk from anaesthesia. Such patients may otherwise be considered “unfit” for endourological intervention. \u0000 \u0000 ","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"102 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133253249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adult Ureteroceles are uncommon, majority of which are asymptomatic and commonly found incidentally. Surgical deroofing is indicated in patients with bothersome symptoms or complications secondary to ureteroceles. Several deroofing techniques has been described in the literature including nephroscopic scissors, collin's knife, and use of lasers in the last two decades became popular. Herein we report a case and demonstare our technique of using Holmium laser to treat an adult with symptomatic obstructive unilateral ureterocele.
{"title":"Holmium Laser Treatment of an Obstructive Ureterocele in an Adult Patient: A Case Report and Video","authors":"O. Abdalla, Y. C. Phan, S. Sriprasad","doi":"10.22374/JELEU.V2I1.27","DOIUrl":"https://doi.org/10.22374/JELEU.V2I1.27","url":null,"abstract":"Adult Ureteroceles are uncommon, majority of which are asymptomatic and commonly found incidentally. Surgical deroofing is indicated in patients with bothersome symptoms or complications secondary to ureteroceles. Several deroofing techniques has been described in the literature including nephroscopic scissors, collin's knife, and use of lasers in the last two decades became popular. Herein we report a case and demonstare our technique of using Holmium laser to treat an adult with symptomatic obstructive unilateral ureterocele. ","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115007015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Sarma, Y. Singh, S. J. Baruah, T. P. Rajeev, S. Barua, P. K. Bagchi, Mandeep Phukan, M. Kashyap
Background and ObjectiveThe thulium laser surgery is a relatively new approach in which a wavelength of approximately 2 μm is emitted in continuous-wave mode, thus enabling the precise incision of tissue by using a wavelength that matches the water absorption peak of 1.92 μm in tissue. However, no published multinational study or other evidence definitively declares the superiority of thulium vaporization (ThuVAP) over thulium vapoenucle-ation (ThuVEP) without morcellator for better management of bothersome benign prostatic hyperplasia. The present study aims to evaluate the efficacy of vaporization and vapoenucleation (without a morcellator) in thulium laser prostatectomy for the treatment of benign prostatic hyperplasia.MethodsA retrospective analysis of 82 patients who underwent thulium laser prostatectomy between February 2017 and January 2018 with ThuVAP and ThuVEP techniques was done and outcome measures analyzed were International Prostate Symptom Score (IPSS), quality-of-life score (QoL), maximum flow rate (Q max), post-void residual (PVRU), total operating time, laser time and resected tissue weight.ResultsNo significant differences were noted between ThuVAP and ThuVEP in terms of post-operative prostate volume (22.4 vs. 21.7 mL) and post-operative prostate specific antigen (PSA) (2.54 vs. 1.85 ng/mL). Nonetheless, there were differences between the groups in total lasing time (56.5 vs. 44.8 min, p = 0.001) and total operative time (88.5 vs. 71.5 min, p= 0.001). There was also a significant difference in IPSS, QoL score, Q max, and PVRU at 6 weeks, 3 months, 6 months and 9 months after surgery.
背景与目的铥激光手术是一种相对较新的手术方式，其波长约为2 μm，以连续波模式发射，从而利用与组织中1.92 μm的吸水峰相匹配的波长来精确切割组织。然而，没有发表的多国研究或其他证据明确表明，在治疗恼人的良性前列腺增生方面，铥汽化(ThuVAP)优于无粉碎剂的铥汽化核(ThuVEP)。本研究旨在评估汽化和汽化核(无粉碎器)在铥激光前列腺切除术中治疗良性前列腺增生的疗效。方法回顾性分析2017年2月至2018年1月期间采用ThuVAP和ThuVEP技术行铥激光前列腺切除术的82例患者，分析结局指标为国际前列腺症状评分(IPSS)、生活质量评分(QoL)、最大血流率(Q max)、空后残留(PVRU)、总手术时间、激光时间和切除组织重量。结果两组患者术后前列腺体积(22.4 vs. 21.7 mL)和前列腺特异性抗原(PSA) (2.54 vs. 1.85 ng/mL)差异无统计学意义。然而，两组在总激光照射时间(56.5 vs. 44.8 min, p= 0.001)和总手术时间(88.5 vs. 71.5 min, p= 0.001)上存在差异。术后6周、3个月、6个月、9个月IPSS、QoL评分、qmax、PVRU差异均有统计学意义。
{"title":"Thulium Laser Vaporization versus Vapoenucleation (without morcellation) Technique for BPH: Do We Have a Winner?","authors":"D. Sarma, Y. Singh, S. J. Baruah, T. P. Rajeev, S. Barua, P. K. Bagchi, Mandeep Phukan, M. Kashyap","doi":"10.22374/jeleu.v2i1.26","DOIUrl":"https://doi.org/10.22374/jeleu.v2i1.26","url":null,"abstract":"Background and ObjectiveThe thulium laser surgery is a relatively new approach in which a wavelength of approximately 2 μm is emitted in continuous-wave mode, thus enabling the precise incision of tissue by using a wavelength that matches the water absorption peak of 1.92 μm in tissue. However, no published multinational study or other evidence definitively declares the superiority of thulium vaporization (ThuVAP) over thulium vapoenucle-ation (ThuVEP) without morcellator for better management of bothersome benign prostatic hyperplasia. The present study aims to evaluate the efficacy of vaporization and vapoenucleation (without a morcellator) in thulium laser prostatectomy for the treatment of benign prostatic hyperplasia.MethodsA retrospective analysis of 82 patients who underwent thulium laser prostatectomy between February 2017 and January 2018 with ThuVAP and ThuVEP techniques was done and outcome measures analyzed were International Prostate Symptom Score (IPSS), quality-of-life score (QoL), maximum flow rate (Q max), post-void residual (PVRU), total operating time, laser time and resected tissue weight.ResultsNo significant differences were noted between ThuVAP and ThuVEP in terms of post-operative prostate volume (22.4 vs. 21.7 mL) and post-operative prostate specific antigen (PSA) (2.54 vs. 1.85 ng/mL). Nonetheless, there were differences between the groups in total lasing time (56.5 vs. 44.8 min, p = 0.001) and total operative time (88.5 vs. 71.5 min, p= 0.001). There was also a significant difference in IPSS, QoL score, Q max, and PVRU at 6 weeks, 3 months, 6 months and 9 months after surgery.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134540558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Transurethral resection of the prostate (TURP) has been the gold standard for the treatment of elderly men with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). However, over the last few years, advances in surgical treatment have led to the development of other treatment modalities. These innovations include convective WAter Vapor Energy (WAVE; Rezum System), prostatic urethral lift (PUL; UroLift System), Prostate Artery Embolisation (PAE) and Aquablation (AQUABEAM System). This review provides an update on these current minimal invasive surgical treatments. The evidence of their safety, tolerability and efficacy in clinical practice is reviewed.
{"title":"Novel Surgical Treatments for Benign Prostatic Hyperplasia","authors":"Blessing Dhliwayo, S. Mukhtar","doi":"10.22374/JELEU.V2I1.29","DOIUrl":"https://doi.org/10.22374/JELEU.V2I1.29","url":null,"abstract":"Transurethral resection of the prostate (TURP) has been the gold standard for the treatment of elderly men with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). However, over the last few years, advances in surgical treatment have led to the development of other treatment modalities. These innovations include convective WAter Vapor Energy (WAVE; Rezum System), prostatic urethral lift (PUL; UroLift System), Prostate Artery Embolisation (PAE) and Aquablation (AQUABEAM System). This review provides an update on these current minimal invasive surgical treatments. The evidence of their safety, tolerability and efficacy in clinical practice is reviewed.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"67 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125170838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：